PARP1 and breast cancer: We found that the pooled HR for DFS according to PARP expression in breast cancer patients was 3.08 (95% CI, 1.14–8.29, P = 0.03), which demonstrated that patients with higher PARP expression experienced significantly worse DFS compared with that in the lower expression group.